Cargando…

CSF chitinase 3-like-1 association with disability of primary progressive MS

OBJECTIVE: To assess the role of CSF chitinase 3-like-1 (CHI3L1), chitinase 3-like-2 (CHI3L2), and neurofilament light chain (NfL) in predicting the course of primary progressive MS (PPMS). METHODS: We analyzed CSF CHI3L1, CHI3L2, and NfL levels in 25 patients with PPMS with disease duration ≤10 yea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pérez-Miralles, Francisco, Prefasi, Daniel, García-Merino, Antonio, Gascón-Giménez, Francisco, Medrano, Nicolás, Castillo-Villalba, Jessica, Cubas, Laura, Alcalá, Carmen, Gil-Perotín, Sara, Gómez-Ballesteros, Rocío, Maurino, Jorge, Álvarez-García, Esther, Casanova, Bonaventura
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7357419/ https://www.ncbi.nlm.nih.gov/pubmed/32611760 http://dx.doi.org/10.1212/NXI.0000000000000815

Ejemplares similares

Combined Cerebrospinal Fluid Neurofilament Light Chain Protein and Chitinase-3 Like-1 Levels in Defining Disease Course and Prognosis in Multiple Sclerosis
por: Gil-Perotin, Sara, et al.
Publicado: (2019)

Potential Role of CHI3L1+ Astrocytes in Progression in MS
por: Cubas-Núñez, Laura, et al.
Publicado: (2021)

Brain region volumes and their relationship with disability progression and cognitive function in primary progressive multiple sclerosis
por: Pérez‐Miralles, Francisco Carlos, et al.
Publicado: (2021)

Progressive Demyelination in the Presence of Serum Myelin Oligodendrocyte Glycoprotein-IgG: A Case Report
por: Gil-Perotin, Sara, et al.
Publicado: (2018)

Onset of secondary progressive multiple sclerosis is not influenced by current relapsing multiple sclerosis therapies
por: Coret, Francisco, et al.
Publicado: (2018)

Perception of stigma in patients with primary progressive multiple sclerosis
por: Pérez-Miralles, Francisco, et al.
Publicado: (2019)

CSF Chitinase 3–Like 2 Is Associated With Long-term Disability Progression in Patients With Progressive Multiple Sclerosis
por: Comabella, Manuel, et al.
Publicado: (2021)

Brain Atrophy in Relapsing Optic Neuritis Is Associated With Crion Phenotype
por: Cantó, Laura Navarro, et al.
Publicado: (2019)

Chitinase 3–like 1 and neurofilament light chain in CSF and CNS atrophy in MS
por: Schneider, Ruth, et al.
Publicado: (2020)

In situ RT-PCR Optimized for Electron Microscopy Allows Description of Subcellular Morphology of Target mRNA-Expressing Cells in the Brain
por: Cubas-Nuñez, Laura, et al.
Publicado: (2017)

Oligoclonal M bands and cervical spinal cord lesions predict early secondary progressive multiple sclerosis
por: Alcalá Vicente, Carmen, et al.
Publicado: (2022)

High Levels of Cerebrospinal Fluid Kappa Free Light Chains Relate to IgM Intrathecal Synthesis and Might Have Prognostic Implications in Relapsing Multiple Sclerosis
por: Castillo-Villalba, Jéssica, et al.
Publicado: (2022)

Decision making under uncertainty, therapeutic inertia, and physicians’ risk preferences in the management of multiple sclerosis (DIScUTIR MS)
por: Saposnik, Gustavo, et al.
Publicado: (2016)

Psychometric properties of the SDM-Q-9 questionnaire for shared decision-making in multiple sclerosis: item response theory modelling and confirmatory factor analysis
por: Ballesteros, Javier, et al.
Publicado: (2017)

CSF chitinases before and after symptom onset in amyotrophic lateral sclerosis
por: Gray, Elizabeth, et al.
Publicado: (2020)

Autologous hematopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: comparison with secondary progressive multiple sclerosis
por: Casanova, Bonaventura, et al.
Publicado: (2017)

Measuring burden in caregivers of people with multiple sclerosis: psychometric properties of the CSI questionnaire
por: García-Domínguez, Jose M, et al.
Publicado: (2019)

Decision-making in Multiple Sclerosis: The Role of Aversion to Ambiguity for Therapeutic Inertia among Neurologists (DIScUTIR MS)
por: Saposnik, Gustavo, et al.
Publicado: (2017)

Quantifying the patient´s perspective in neuromyelitis optica spectrum disorder: Psychometric properties of the SymptoMScreen questionnaire
por: Meca-Lallana, José E., et al.
Publicado: (2021)

Sustained hyperammonemia induces TNF-a IN Purkinje neurons by activating the TNFR1-NF-κB pathway
por: Balzano, Tiziano, et al.
Publicado: (2020)

Escalation vs. Early Intense Therapy in Multiple Sclerosis
por: Casanova, Bonaventura, et al.
Publicado: (2022)

Case Report: Exacerbation of Relapses Following mRNA COVID-19 Vaccination in Multiple Sclerosis: A Case Series
por: Quintanilla-Bordás, Carlos, et al.
Publicado: (2022)

Treatment of Multiple Sclerosis With Teriflunomide. Multicenter Study of Real Clinical Practice in the Valencian Community-Spain
por: Landete, Lamberto, et al.
Publicado: (2021)

Treatment of multiple sclerosis with rituximab: A Spanish multicenter experience
por: Gascón-Giménez, Francisco, et al.
Publicado: (2023)

Impact of Neuromyelitis Optica Spectrum Disorder on Quality of Life from the Patients’ Perspective: An Observational Cross-Sectional Study
por: Meca-Lallana, José E., et al.
Publicado: (2022)

A Pilot Study to Explore Patient Satisfaction With a Virtual Rehabilitation Program in Multiple Sclerosis: The RehabVR Study Protocol
por: Meca-Lallana, Virginia, et al.
Publicado: (2020)

Chitinase-3-like 1-protein in CSF: a novel biomarker for progression in patients with multiple sclerosis
por: Talaat, Foraysa, et al.
Publicado: (2023)

Economic burden of multiple sclerosis in a population with low physical disability
por: García-Domínguez, José M., et al.
Publicado: (2019)

Correction to: Economic burden of multiple sclerosis in a population with low physical disability
por: García-Domínguez, José M., et al.
Publicado: (2019)

Chitinases and chitinase-like proteins as biomarkers in neurologic disorders
por: Pinteac, Rucsanda, et al.
Publicado: (2020)

CSF CXCL13 and Chitinase 3-like-1 Levels Predict Disease Course in Relapsing Multiple Sclerosis
por: Lucchini, Matteo, et al.
Publicado: (2022)

Chitinases: An update
por: Hamid, Rifat, et al.
Publicado: (2013)

Molecular identification of the chitinase genes in Plasmodium relictum
por: Garcia-Longoria, Luz, et al.
Publicado: (2014)

Human Chitinases and Chitinase-Like Proteins as Indicators for Inflammation and Cancer
por: Kzhyshkowska, Julia, et al.
Publicado: (2007)

Chitin, Chitinases and Chitinase-like Proteins in Allergic Inflammation and Tissue Remodeling
por: Lee, Chun Geun
Publicado: (2009)

The role of chitin, chitinases, and chitinase-like proteins in pediatric lung diseases
por: Mack, Ines, et al.
Publicado: (2015)

miRNA Signature in CSF From Patients With Primary Progressive Multiple Sclerosis
por: Muñoz-San Martín, María, et al.
Publicado: (2022)

Chitinases as Food Allergens
por: Leoni, Claudia, et al.
Publicado: (2019)

Neutrophils as a Source of Chitinases and Chitinase-Like Proteins in Type 2 Diabetes
por: Żurawska-Płaksej, Ewa, et al.
Publicado: (2015)

Is CSF neurofilament light chain measurement relevant for MS?
por: Matsui, Makoto
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_eiuv66da0toa9e6kq7s4tgkei8